GW Henssler & Associates Ltd. Takes Position in Clorox Co. (CLX)
GW Henssler & Associates Ltd. acquired a new position in Clorox Co. (NYSE:CLX) during the second quarter, Holdings Channel reports. The fund acquired 1,448 shares of the company’s stock, valued at approximately $200,000.
Several other institutional investors also recently added to or reduced their stakes in CLX. Invictus RG bought a new position in Clorox during the first quarter worth about $110,000. Checchi Capital Advisers LLC boosted its position in Clorox by 1.0% in the second quarter. Checchi Capital Advisers LLC now owns 820 shares of the company’s stock worth $113,000 after buying an additional 8 shares during the period. Parsec Financial Management Inc. bought a new position in Clorox during the second quarter worth about $215,000. Mutual of Omaha Bank Wealth Management boosted its position in Clorox by 14.6% in the second quarter. Mutual of Omaha Bank Wealth Management now owns 2,350 shares of the company’s stock worth $226,000 after buying an additional 300 shares during the period. Finally, Paragon Capital Management Ltd bought a new position in Clorox during the second quarter worth about $232,000. 70.20% of the stock is currently owned by institutional investors.
Clorox Co. (NYSE:CLX) traded up 0.30% during midday trading on Monday, reaching $122.13. 507,134 shares of the company’s stock traded hands. The firm’s 50-day moving average is $125.33 and its 200 day moving average is $129.68. Clorox Co. has a 52-week low of $119.23 and a 52-week high of $140.47. The firm has a market cap of $15.81 billion, a PE ratio of 24.82 and a beta of 0.30.
Clorox (NYSE:CLX) last posted its quarterly earnings data on Wednesday, August 3rd. The company reported $1.26 EPS for the quarter, missing the consensus estimate of $1.28 by $0.02. Clorox had a return on equity of 296.91% and a net margin of 11.25%. The business had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.58 billion. During the same period in the previous year, the firm earned $1.44 EPS. The company’s revenue was up 2.8% on a year-over-year basis. Equities research analysts expect that Clorox Co. will post $5.49 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 14th. Investors of record on Wednesday, October 26th will be paid a dividend of $0.80 per share. This represents a $3.20 annualized dividend and a yield of 2.62%. The ex-dividend date of this dividend is Monday, October 24th. Clorox’s payout ratio is currently 64.91%.
A number of equities analysts have recently issued reports on CLX shares. Zacks Investment Research raised shares of Clorox from a “hold” rating to a “buy” rating and set a $148.00 price objective on the stock in a research report on Monday, August 8th. Atlantic Securities raised shares of Clorox from a “hold” rating to a “buy” rating and set a $144.00 price objective on the stock in a research report on Friday, September 16th. Jefferies Group reissued a “hold” rating on shares of Clorox in a research report on Wednesday, August 3rd. Deutsche Bank AG reaffirmed a “hold” rating and issued a $134.00 price target (up previously from $130.00) on shares of Clorox in a research report on Sunday, July 24th. Finally, B. Riley reaffirmed a “neutral” rating and issued a $109.00 price target on shares of Clorox in a research report on Tuesday, August 9th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $127.80.
In other news, COO Dawn C. Willoughby sold 10,617 shares of the company’s stock in a transaction that occurred on Wednesday, August 17th. The shares were sold at an average price of $131.01, for a total value of $1,390,933.17. Following the transaction, the chief operating officer now owns 20,353 shares in the company, valued at $2,666,446.53. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Laura Stein sold 38,882 shares of the company’s stock in a transaction that occurred on Friday, September 2nd. The stock was sold at an average price of $131.69, for a total transaction of $5,120,370.58. Following the completion of the transaction, the executive vice president now owns 48,501 shares in the company, valued at approximately $6,387,096.69. The disclosure for this sale can be found here. Corporate insiders own 0.74% of the company’s stock.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co. (NYSE:CLX).
Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with MarketBeat.com's FREE daily email newsletter.